NexMed, Inc.
www.nexmed.comNexMed, USA is a wholly owned subsidiary of Apricus Biosciences (NASDAQ:APRI). The Company has a proprietary drug delivery technology, NexACT, which has been used to develop an impressive drug product pipeline, ranging from the pre-clinical stage to the NDA stage.
Read more
NexMed, USA is a wholly owned subsidiary of Apricus Biosciences (NASDAQ:APRI). The Company has a proprietary drug delivery technology, NexACT, which has been used to develop an impressive drug product pipeline, ranging from the pre-clinical stage to the NDA stage.
Read more
Country
State
California
City (Headquarters)
San Diego
Industry
Employees
11-50
Estimated Revenue
$1,000,000 to $5,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Owner
Email ****** @****.comPhone (***) ****-****Director and Content Manager Advisory Board
Email ****** @****.comPhone (***) ****-****Business Development Director
Email ****** @****.comPhone (***) ****-****Manager
Email ****** @****.comPhone (***) ****-****
Technologies
(2)
Reach decision makers at NexMed, Inc.
Free credits every month!
NexMed, Inc. FAQ
San Diego, United States
Biotechnology Research
